FiercePharma

New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug

BALTIMORE, Aug. 14, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that the new BD MAX™ MRSA molecular test has received a Moderate ...
Pharmabiz

Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide

Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide: San Diego Friday, February ...
Targeted Oncology

FDA Expands Approval of Aptima HPV Assay for Cervical Cancer Primary Screening

The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
Business Wire

Genomic Vision Reduces Replication Combing Assay Turnaround Time for Pharmaceutical Industry and Advances Drug Discovery and Oncology

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: Genomic Vision (FR0011799907 – GV – the “Company”), a Euronext-listed biotechnology company that develops products and services for the highly ...
GlobalData on MSN

Hologic’s Aptima assay secures FDA approval for HPV primary screening

With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and ...
FiercePharma

Ventana Medical Systems, Inc. Receives FDA Approval for the First Fully Automated Diagnostic Assay for HER2 Gene Status Determin

TUCSON, Ariz., June 14, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today that the FDA approved the INFORM HER2 Dual ISH DNA Probe cocktail ...
Nasdaq

ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant

ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with details of a supplier agreement with AstraZeneca PLC to develop an androgen receptor (AR) detection assay to enhance ...
Business Insider

Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration Leveraging Caris' Novel, Blood-Based cNAS Molecular Profiling Assay Across Several Ono Clinical Studies

IRVING, Texas, and OSAKA, Japan, Oct. 14, 2021 /PRNewswire/ -- Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, and Ono ...

BETMAT: LAL BET Detection Kit Supplier At The Forefront Of Pharmaceutical Quality Control

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...
Nasdaq

Journal of Pharmaceutical & Biomedical Analysis Publishes Study Analytically Validating OncoHost's PROphet® Test as a Decision Support Tool for Metastatic NSCLC Patients

Peer-reviewed paper reveals proteomic assay's strong analytical capabilities, enabling robust and reproducible predictions for truly personalized treatment guidance In an era marked by technological ...
FierceBiotech

Assay Depot Secures Financing to Expand Cloud-Based Pharmaceutical Research Platform

SAN DIEGO--(BUSINESS WIRE)--Assay Depot announced today that it raised $1.7 million from private investors. The funds will be used to expand the company's cloud-based pharmaceutical research platform.
Rutland Herald

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...